Rethinking cost-effectiveness in the era of zero healthcare spending growth

被引:0
|
作者
Ronen Arbel
Dan Greenberg
机构
[1] Ben-Gurion University of the Negev,Department of Health Systems Management, Faculty of Health Sciences and The Guilford
[2] Sapir Academic College,Glazer Faculty of Business and Management
关键词
Health Equity; Budget Impact; Cost-Effectiveness; Decision Making; Economic Outcome;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] RETHINKING COST-EFFECTIVENESS IN THE ERA OF ZERO HEALTHCARE SPENDING GROWTH
    Arbel, R.
    Greenberg, D.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A37 - A37
  • [2] Rethinking cost-effectiveness in the era of zero healthcare spending growth
    Arbel, Ronen
    Greenberg, Dan
    [J]. INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2016, 15
  • [3] RETHINKING COST-EFFECTIVENESS
    BELKIN, NL
    [J]. HOSPITALS & HEALTH NETWORKS, 1994, 68 (13): : 4 - 4
  • [4] Cost-Effectiveness of Cardiovascular Disease Spending
    Miller, George
    Cohen, Joshua T.
    Roehrig, Charles
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (20) : 2123 - 2124
  • [5] The cost-effectiveness of resilient healthcare
    Saurin, Tarcisio Abreu
    Wiig, Siri
    Patriarca, Riccardo
    Grotan, Tor Olav
    [J]. INTERNATIONAL JOURNAL OF HEALTH GOVERNANCE, 2023, 28 (03) : 319 - 327
  • [6] Spending to save? The cost-effectiveness of conflict prevention
    Chalmers, Malcolm
    [J]. DEFENCE AND PEACE ECONOMICS, 2007, 18 (01) : 1 - 23
  • [7] Impact of Disease Management on Cost-Effectiveness of Medicare Spending
    Joshua Cohen
    Cherie Poquetie
    [J]. Drug information journal : DIJ / Drug Information Association, 2003, 37 : 329 - 339
  • [8] Impact of disease management on cost-effectiveness of medicare spending
    Cohen, J
    Paquette, C
    [J]. DRUG INFORMATION JOURNAL, 2003, 37 (03): : 329 - 339
  • [9] The marginal benefits of healthcare spending in the Netherlands: Estimating cost-effectiveness thresholds using a translog production function
    Stadhouders, Niek
    Koolman, Xander
    van Dijk, Christel
    Jeurissen, Patrick
    Adang, Eddy
    [J]. HEALTH ECONOMICS, 2019, 28 (11) : 1331 - 1344
  • [10] The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics
    Christopher R. Flowers
    David Veenstra
    [J]. PharmacoEconomics, 2004, 22 : 481 - 493